Description of Business and Significant Accounting Policies - Liquidity and Basis of Presentation (Details Narrative) (USD $)
|
0 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||||
---|---|---|---|---|---|---|---|---|---|
Nov. 12, 2014
|
Oct. 31, 2014
|
Jul. 31, 2014
|
Oct. 31, 2013
|
Oct. 31, 2014
|
Oct. 31, 2013
|
Apr. 30, 2014
|
Apr. 30, 2013
|
Apr. 30, 2012
|
|
Debt Instrument [Line Items] | |||||||||
Net loss | $ (1,506,961) | $ (2,266,728) | $ (338,192) | $ (2,266,728) | $ (1,219,822) | $ (2,609,000) | $ (4,625,000) | $ (3,259,000) | |
Net cash used in operating activities | (256,009) | (47,258) | (1,554,000) | (3,882,000) | (1,218,000) | ||||
Subordinated secured convertible bridge notes | 750,000 | 750,000 | |||||||
Conversion price | $ 2.00 | ||||||||
Bridge notes, maturity date | Jan. 15, 2015 | ||||||||
Warrants issued in connection with the bridge notes, terms | The Warrants are exercisable for five years after the closing date of the Purchase Agreement. For each $1,000 of principal amount of Bridge Notes, the holder received 1,200 Warrants to purchase the Companys common stock. Each holder is entitled to exercise one-third of all warrants received at an exercise price of $3.00, one-third of all warrants received at an exercise price of $3.50, and one-third of all warrants received at an exercise price that is equal to the closing price on the closing date of the Purchase Agreement, $2.94. Pursuant to the terms of the Purchase Agreement, the Company has agreed to register the shares underlying the Bridge Notes and the Warrants. | ||||||||
Preferred stock contract terms | Two additional 90 extensions were provided to the institutional investors, which could extend the final maturity date to July 15, 2015. At any time from November 17, 2014, the date of Closing, and prior to October 20, 2019 (the Put/Call Exercise Period), the Series A Investors may exercise a right to purchase and require the Company to sell up to an additional 700,000 shares of Series A Stock on terms identical to the terms for the original sale of the Series A Stock, except that, upon such exercise, no additional Preferred Warrants are granted. If the Series A Investors have not exercised this right in full during the Put/Call Exercise Period, the Company may exercise a right to cause and require the Series A Investors to purchase any or all of such otherwise unpurchased 700,000 shares of Series A Stock on terms identical to the terms for the original sale of the Series A Stock, except that, upon such exercise, no additional Preferred Warrants are granted, in either case for an aggregate purchase price of up to $3,500,000. If current and projected revenue growth does not meet estimates, the Company may call upon the remaining Series A Stock available for sale. There are 700,000 Series A Shares available for call by the Company at $5.00 per share. | ||||||||
Sale of Series A preferred stock | 600,000 | ||||||||
Proceeds from issuance of private placement | 2,700,000 | ||||||||
Institutional Investor | |||||||||
Debt Instrument [Line Items] | |||||||||
Subordinated secured convertible bridge notes | 600,000 | 600,000 | |||||||
Conversion price | $ 2.50 | $ 2.50 | |||||||
Bridge notes, maturity date | Jan. 15, 2015 | ||||||||
Bridge notes, interest rate | 8.00% | 8.00% | |||||||
Management | |||||||||
Debt Instrument [Line Items] | |||||||||
Subordinated secured convertible bridge notes | $ 150,000 | $ 150,000 | |||||||
Conversion price | $ 2.94 | $ 2.94 | |||||||
Bridge notes, maturity date | Jan. 15, 2015 | ||||||||
Bridge notes, interest rate | 8.00% | 8.00% |